Sorcha Eastwood

The Secretary of State shared an update on the discussions with Harland and Wolff through a Written Ministerial Statement on 22^nd July. The statement can be found here: https://questions-statements.parliament.uk/written-statements/detail/2024-07-22/hcws15

Education is a devolved matter, and the response outlines the information for England only.

Meeting the skills needs of the next decade is central to delivering the government’s mission. To support business and boost opportunity, the department will transform the existing Apprenticeship Levy into a more flexible Growth and Skills Levy. This will allow employers to invest in a wider range of training and empower them to upskill their workforces for current and future challenges.

The department has already established Skills England which will work closely with employers, training providers, unions, Mayoral Combined Authorities and others across the skills landscape to identify the training for which the Growth and Skills Levy will be accessible.

Supporting parents with care and compassion whilst they navigate some of the toughest moments a parent can face is something all in this house would believe in. We will consider the work done by the previous Government before making a decision on next steps.

Other than for those who are nearing the end of their life, the extra costs disability benefits, such as Personal Independence Payment (PIP) and Disability Living Allowance (DLA), are assessed on the basis of the needs arising from a long-term health condition or disability rather than a diagnosis. PIP has replaced DLA for working age people. DLA is claimed by children under the age of 16 years old. Children and young people who have been diagnosed with cancer and who face extra costs as a result of their ill health can apply for DLA immediately. The qualifying period does not apply to DLA claimants who are terminally ill and do not have to satisfy the three--month qualifying period. They will have their claim fast tracked and are eligible for the higher-rate care component from the date of claim.

The Department supports people nearing the end of life through the Special Rules for End of Life, as they will incur additional costs for additional care and support. We enable children and young people who are nearing the end of their lives to get faster, easier access to the extra costs disability benefits with a guaranteed entitlement.

The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used in the treatment of cystic fibrosis and certain cancers, including pancreatic cancer. The supply issues are impacting countries throughout Europe, and have been caused by the limited availability of raw ingredients and manufacturing capacity constraints in producing the volumes needed to meet demand. The Department is continuing to work with all suppliers of PERT to help resolve the supply issues in the short and longer term. This includes asking that they expedite deliveries, source stock from other markets, and increase production.

We have issued comprehensive guidance to healthcare professionals about these supply issues, which provides advice on how to manage patients whilst there is disruption to supply. This guidance is being kept under review, and updates will be made as necessary. Serious Shortage Protocols are in place for Creon 10,000 and 25,000 capsules to limit prescriptions to one months’ supply, to allow demand management.

We understand how frustrating and distressing medicine supply issues can be. While we can’t always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise, and to help mitigate risks to patients.

The Department is responsible for healthcare in England. In Northern Ireland, health is a transferred matter, and for Scotland and Wales, health is a devolved matter. The Government has not yet made a formal assessment on a cancer plan for children and young people, or a United Kingdom-wide cancer needs delivery group. However, as part of the Department’s work to improve the experience and outcomes for children and young people with cancer in England, Department officials have previously undertaken some engagement work with stakeholders across the cancer sector to gain a further understanding of the unique needs and challenges for children and young people with cancer in England. This engagement included exploring key issues in relation to detection and diagnosis, genomic testing and treatment, and research and innovation. While the initial focus has been on children and young people’s cancer services in England, the Department is keen to expand collaboration in order to benefit children and young people’s cancer outcomes as widely as possible.

Department officials regularly meet with counterparts from other Government departments and the devolved administrations, to support research and access to clinical trials across the UK. The Department is committed to ensuring clinical trials are people-centred and more accessible, including for children and young people. This will involve making it easier for patients, service users, and members of the public across the UK to access and participate in research, if they want to. Our aim is to lead the world in clinical trials and ensure that all patients, their families, and their carers are empowered to directly and proactively explore research opportunities, and to make informed decisions about participating in research.

At this stage the Department has not made a formal assessment of the adequacy of support for travel for young cancer patients, including schemes for young cancer patients from Northern Ireland travelling to receive treatment in England, or the merits of establishing a UK-wide travel fund. NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities are met, including providing support for travel. The National Health Service runs schemes in England to provide financial assistance for travel to a hospital or other NHS premises for specialist NHS treatment or diagnostics tests, when referred by a doctor or other primary healthcare professional. The Healthcare Travel Costs Scheme (HTCS) provides financial assistance to patients in England who do not have a medical need for transport, but who require assistance with the costs of travelling to receive certain NHS services. Patients who do not qualify for the HTCS and are on a low income may be able to claim the costs from the Department for Work and Pensions through Universal Credit or Personal Independence Payment.

The Department is responsible for healthcare in England. In Northern Ireland, health is a transferred matter, and for Scotland and Wales, health is a devolved matter. The Government has not yet made a formal assessment on a cancer plan for children and young people, or a United Kingdom-wide cancer needs delivery group. However, as part of the Department’s work to improve the experience and outcomes for children and young people with cancer in England, Department officials have previously undertaken some engagement work with stakeholders across the cancer sector to gain a further understanding of the unique needs and challenges for children and young people with cancer in England. This engagement included exploring key issues in relation to detection and diagnosis, genomic testing and treatment, and research and innovation. While the initial focus has been on children and young people’s cancer services in England, the Department is keen to expand collaboration in order to benefit children and young people’s cancer outcomes as widely as possible.

Department officials regularly meet with counterparts from other Government departments and the devolved administrations, to support research and access to clinical trials across the UK. The Department is committed to ensuring clinical trials are people-centred and more accessible, including for children and young people. This will involve making it easier for patients, service users, and members of the public across the UK to access and participate in research, if they want to. Our aim is to lead the world in clinical trials and ensure that all patients, their families, and their carers are empowered to directly and proactively explore research opportunities, and to make informed decisions about participating in research.

At this stage the Department has not made a formal assessment of the adequacy of support for travel for young cancer patients, including schemes for young cancer patients from Northern Ireland travelling to receive treatment in England, or the merits of establishing a UK-wide travel fund. NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities are met, including providing support for travel. The National Health Service runs schemes in England to provide financial assistance for travel to a hospital or other NHS premises for specialist NHS treatment or diagnostics tests, when referred by a doctor or other primary healthcare professional. The Healthcare Travel Costs Scheme (HTCS) provides financial assistance to patients in England who do not have a medical need for transport, but who require assistance with the costs of travelling to receive certain NHS services. Patients who do not qualify for the HTCS and are on a low income may be able to claim the costs from the Department for Work and Pensions through Universal Credit or Personal Independence Payment.

Cancer remains a priority area for the Government, and £1.5 billion has been invested on health research through the National Institute for Health and Care Research (NIHR). The NIHR’s research expenditure for all cancers was over £121.8 million for 2022/23, with more spent on cancer than any other disease group. The overall budget for research investment is agreed with the Treasury at the outset of each Spending Review period, and the Department regularly engages with the Chancellor of the Exchequer about a range of issues.

Our investments in cancer are pivotal to informing efforts to improve cancer prevention, treatment, and care.

The NIHR continues to encourage and welcome applications for research into any aspect of human health, including all cancer types. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients, health and care services, value for money, and scientific quality.

£1.5 billion per year is invested by the Department of Health and Social Care on health research through the National Institute for Health and Care Research (NIHR).The NIHR research expenditure for all cancers was over £121.8 million for 2022/23, with more spent on cancer than any other disease group. Over £20 million of this was spent on Leukaemia research specifically.

In 2022/23 alone, the NIHR Cancer Research Network supported over 950 cancer research studies involving over 90,000 participants. Further investments in 10 Biomedical Research Centres and a network of Experimental Cancer Medicine Centres are supporting the discovery, development, and testing of new cancer treatments, including through hospital-based clinical trials, across the country.

The NIHR continues to encourage and welcome applications for research into any aspect of human health, including blood and all other cancers. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality, rather than against specific disease funding allocations. We would welcome more applications from researchers working on cancer prevention, treatment, and care.

Regulating Buy Now Pay Later products is crucial to protect people and deliver certainty for the sector.

The government will be looking to work closely with all interested stakeholders and will set out its plans shortly.

The UK government website has guidance on all our immigration rules and criteria, including the requirements of the Student route and the study conditions of the Graduate route: Visas and immigration - GOV.UK (www.gov.uk).

The Common Travel Area (CTA) supports the long-standing principle of free movement for British and Irish citizens between the UK, Ireland and the Crown Dependencies (Jersey, Guernsey and the Isle of Man) and has been recognised in law since the 1920s.

In support of the Belfast (Good Friday) Agreement there is no hard border and no immigration controls between Northern Ireland and Ireland and as part of the wider CTA arrangements the UK does not operate routine immigration controls on journeys made within the CTA.

The details of the Border Security, Asylum and Immigration Bill and the assessment of the Bill’s impact will be set out in due course.

The new Home Secretary will decide on the future of current Home Office policies in due course. Any changes will be announced to Parliament in the normal way.

The new Home Secretary will decide on the future of current Home Office policies in due course. Any changes will be announced to Parliament in the normal way.

The new Home Secretary will decide on the future of current Home Office policies in due course. Any changes will be announced to Parliament.

To date, I have not requested a review of (a) a Troubles-related death under section 9(3) of the Northern Ireland Troubles (Legacy and Reconciliation) Act 2023, or of (b) harmful conduct under section 10(2) of that Act. This was also the case for my predecessor.

The Commission is independent of Government. As such, it would not be appropriate for the Government to publish information about its operational activities. This is a matter for the commission, which is, I know, committed to openness in its work.

The UK Government is committed to ensuring that EURO 2028 benefits the whole of the United Kingdom. That is why we are working as quickly as possible with all the partners involved in the Casement Park project to assess the options available.

The UK Government is committed to ensuring that EURO 2028 benefits the whole of the United Kingdom. That is why we are working as quickly as possible with all the partners involved in the Casement Park project to assess the options available.